search
Back to results

CALIBER Phase 1: A Pilot Study in Normal-weight and Overweight Adults. (CALIBER)

Primary Purpose

Cardiometabolic Risk

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Low-carbohydrate, high-fat
High-carbohydrate, moderate-fat
Sponsored by
Liverpool John Moores University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cardiometabolic Risk

Eligibility Criteria

19 Years - 64 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria cohort 1:

  1. BMI 18.5 - 29.9kg/m2
  2. Aged 19 - 64
  3. White-Caucasian
  4. Score of ≥4 from a combination of risk markers, including

    • Fasting glucose concentration >5.5mmol/L = 3 points
    • Waist >102cm or 40 inches = 2 points (males)
    • Waist >94 cm or 37 inches = 1 point (males)
    • Waist >88cm or 34inches = 2 points (females)
    • Waist >80 cm or 31 inches = 1 point (females)
    • Systolic blood pressure>130mmHg = 1 point
    • Diastolic BP >85mmHg = 1 point
    • HDL cholesterol concentration <1.0mmol/L = 2 points
    • Serum triglyceride concentration >1.3mmol/L = 1 point.

Exclusion Criteria cohort 1:

  1. Smoker
  2. Vegetarian or vegan
  3. Suffering from food allergies or intolerances
  4. Drinking alcohol above recommended UK government guidelines
  5. Previous diagnosis of CM disease
  6. Taking lipid-lowering medication
  7. Taking blood pressure-lowering medication
  8. Taking blood glucose-lowering medication
  9. Taking dietary supplements
  10. Suffering from an eating disorder
  11. Current or previous renal impairment

Inclusion Criteria cohort 2:

  1. BMI 18.5 - 29.9kg/m2
  2. Aged 19 - 64
  3. White-Caucasian

Exclusion Criteria cohort 2:

  1. Smoker
  2. Vegetarian or vegan
  3. Suffering from food allergies or intolerances
  4. Drinking alcohol above recommended UK government guidelines
  5. Previous diagnosis of CM disease
  6. Taking lipid-lowering medication
  7. Taking blood pressure-lowering medication
  8. Taking blood glucose-lowering medication
  9. Taking dietary supplements
  10. Suffering from an eating disorder
  11. Current or previous renal impairment

Sites / Locations

  • Liverpool John Moores University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Low-carbohydrate, high-fat

High-carbohydrate, moderate fat

Arm Description

Participants adhering to low-carbohydrate, high-fat diet for 8 weeks.

Participants following high-carbohydrate, moderate-fat diet for 8 weeks.

Outcomes

Primary Outcome Measures

Serum lipid profile
Total cholesterol, HDL-C, LDL-C, non-HDL cholesterol, small-dense LDL-C and triglycerides measured in mmol/L
Blood glucose
Measured in mmol/L
Systolic and diastolic blood pressure
Measured in mmHg
Inflammatory markers, such as CRP
Measured in mg/L
Adiponectin
Measured in μg/mL
Fibroblast growth factor 21 (FGF21).
Measured in pg/mL
Tumor necrosis factor alpha and Interleukin 6
Measured in μg/mL
Body composition - Bioelectrical impedance
Lean mass, fat mass and adipose tissue location and distribution
Body composition - Anthropometrics
Waist, hip, neck, thigh and calf circumference measured in cm

Secondary Outcome Measures

Clinical traditional and emerging markers of dietary intake
Fibroblast growth factor 21 and serum metabolites
Food cravings
Measured via self-reported questionnaire
Satiety
Assessed via serum leptin levels (ng/mL)
Cognition
Assessed via self-reported questionnaire
Impact on physical activity patterns
Assessed via accelerometry
Adherence to assigned diet
Measured via 4-day food diaries
Adherence to dietary guidelines
Measured via diet quality score assessment
Adherence to low-carbohydrate diet
Measured via blood ketones (mmol/L)
Adherence to fibre recommendations
Measured via structured questionnaires
Adherence to taking dietary supplement for low-carbohydrate, high-fat group
Measured via counting of number of multi-vitamin and mineral supplements consumed
Experience with either low-carbohydrate, high-fat or high-carbohydrate, moderate-fat diet
Assessed via semi-structured interview

Full Information

First Posted
August 14, 2017
Last Updated
March 7, 2018
Sponsor
Liverpool John Moores University
Collaborators
Liverpool Hope University
search

1. Study Identification

Unique Protocol Identification Number
NCT03257085
Brief Title
CALIBER Phase 1: A Pilot Study in Normal-weight and Overweight Adults.
Acronym
CALIBER
Official Title
CALIBER (Carbohydrates, Lipids and Biomarkers of Traditional and Emerging Cardiometabolic Risk Factors) Phase 1: A Pilot Study in Normal-weight and Overweight Adults.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2018
Overall Recruitment Status
Completed
Study Start Date
March 9, 2017 (Actual)
Primary Completion Date
December 8, 2017 (Actual)
Study Completion Date
December 8, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Liverpool John Moores University
Collaborators
Liverpool Hope University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Pilot study to compare the impact of following a low-carbohydrate, high-fat diet versus following a high-carbohydrates, moderate-fat diet (UK dietary guidelines) on cardiometabolic risk markers and associated behaviours in a normal-weight and overweight adult population.
Detailed Description
Cardiometabolic diseases (CMD), such as type 2 diabetes and cardiovascular disease (CVD), are globally amongst the highest contributors to morbidity and mortality with high (cost) implications to the overall economy and health care systems. A number of risk markers have been associated with CMDs, including blood serum markers, low levels of lean mass and high levels of body fat, including increased waist circumference. Dietary factors and nutritional status have long been linked with specific markers of cardiometabolic (CM) risk. The quantity and quality of dietary carbohydrates has been associated with increased serum triglycerides levels, increased body fat mass, increased waist circumference and visceral fat around the organs in particular. They also seem to increase food cravings. Whilst official dietary guidelines in the UK and elsewhere still recommend a high carbohydrate and low fat diet as standard, these recommendations have increasingly been challenged. Evidence has been mounting that very-low carbohydrate (ketogenic) and low carbohydrate diets can ameliorate CM risk factors, especially when a personalised rather than a one-size-fits-all approach is being taken. Response to carbohydrate load and adherence to dietary interventions can vary widely dependent on individual substrate and energy metabolism and insulin-resistant status. The majority of dietary interventions with ketogenic and low-carbohydrate diets has focused on weight loss as the primary outcome in overweight and obese individuals. However, in recent years evidence has been mounting that the location and quality of adipose tissue (AT) play a more important role in manifestation of CM risk than quantity of AT alone. Detrimental health behaviours, such as low-quality diet and low levels of physical activity seem to be important contributors to this. Further studies can provide vital insights into the links between diet, location-specific adipose tissue, CM risk factors and health-related behaviours. Therefore this 8-weeks randomised pilot study will investigate the impact of either following a low-carbohydrate, high-fat diet versus following a high-carbohydrates, moderate-fat diet (UK dietary guidelines) on cardiometabolic risk markers and associated behaviours in a normal-weight and overweight adult population aged 19 - 64 at potential risk of CMD.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiometabolic Risk

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomised pilot study
Masking
None (Open Label)
Masking Description
Due to the nature of the low-carbohydrate, high-fat and high-carbohydrate, moderate-fat diets masking is not feasible.
Allocation
Randomized
Enrollment
15 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Low-carbohydrate, high-fat
Arm Type
Experimental
Arm Description
Participants adhering to low-carbohydrate, high-fat diet for 8 weeks.
Arm Title
High-carbohydrate, moderate fat
Arm Type
Experimental
Arm Description
Participants following high-carbohydrate, moderate-fat diet for 8 weeks.
Intervention Type
Other
Intervention Name(s)
Low-carbohydrate, high-fat
Other Intervention Name(s)
CALIBER LCHF
Intervention Description
Participants following low-carbohydrate, high-fat diet for 8 weeks.
Intervention Type
Other
Intervention Name(s)
High-carbohydrate, moderate-fat
Other Intervention Name(s)
CALIBER HCMF
Intervention Description
Participants following high-carbohydrate, moderate-fat diet (UK dietary guidelines) for 8 weeks.
Primary Outcome Measure Information:
Title
Serum lipid profile
Description
Total cholesterol, HDL-C, LDL-C, non-HDL cholesterol, small-dense LDL-C and triglycerides measured in mmol/L
Time Frame
8 weeks
Title
Blood glucose
Description
Measured in mmol/L
Time Frame
8 weeks
Title
Systolic and diastolic blood pressure
Description
Measured in mmHg
Time Frame
8 weeks
Title
Inflammatory markers, such as CRP
Description
Measured in mg/L
Time Frame
8 weeks
Title
Adiponectin
Description
Measured in μg/mL
Time Frame
8 weeks
Title
Fibroblast growth factor 21 (FGF21).
Description
Measured in pg/mL
Time Frame
8 weeks
Title
Tumor necrosis factor alpha and Interleukin 6
Description
Measured in μg/mL
Time Frame
8 weeks
Title
Body composition - Bioelectrical impedance
Description
Lean mass, fat mass and adipose tissue location and distribution
Time Frame
8 weeks
Title
Body composition - Anthropometrics
Description
Waist, hip, neck, thigh and calf circumference measured in cm
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Clinical traditional and emerging markers of dietary intake
Description
Fibroblast growth factor 21 and serum metabolites
Time Frame
8 weeks
Title
Food cravings
Description
Measured via self-reported questionnaire
Time Frame
8 weeks
Title
Satiety
Description
Assessed via serum leptin levels (ng/mL)
Time Frame
8 weeks
Title
Cognition
Description
Assessed via self-reported questionnaire
Time Frame
8 weeks
Title
Impact on physical activity patterns
Description
Assessed via accelerometry
Time Frame
8 weeks
Title
Adherence to assigned diet
Description
Measured via 4-day food diaries
Time Frame
8 weeks
Title
Adherence to dietary guidelines
Description
Measured via diet quality score assessment
Time Frame
8 weeks
Title
Adherence to low-carbohydrate diet
Description
Measured via blood ketones (mmol/L)
Time Frame
8 weeks
Title
Adherence to fibre recommendations
Description
Measured via structured questionnaires
Time Frame
8 weeks
Title
Adherence to taking dietary supplement for low-carbohydrate, high-fat group
Description
Measured via counting of number of multi-vitamin and mineral supplements consumed
Time Frame
8 weeks
Title
Experience with either low-carbohydrate, high-fat or high-carbohydrate, moderate-fat diet
Description
Assessed via semi-structured interview
Time Frame
8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria cohort 1: BMI 18.5 - 29.9kg/m2 Aged 19 - 64 White-Caucasian Score of ≥4 from a combination of risk markers, including Fasting glucose concentration >5.5mmol/L = 3 points Waist >102cm or 40 inches = 2 points (males) Waist >94 cm or 37 inches = 1 point (males) Waist >88cm or 34inches = 2 points (females) Waist >80 cm or 31 inches = 1 point (females) Systolic blood pressure>130mmHg = 1 point Diastolic BP >85mmHg = 1 point HDL cholesterol concentration <1.0mmol/L = 2 points Serum triglyceride concentration >1.3mmol/L = 1 point. Exclusion Criteria cohort 1: Smoker Vegetarian or vegan Suffering from food allergies or intolerances Drinking alcohol above recommended UK government guidelines Previous diagnosis of CM disease Taking lipid-lowering medication Taking blood pressure-lowering medication Taking blood glucose-lowering medication Taking dietary supplements Suffering from an eating disorder Current or previous renal impairment Inclusion Criteria cohort 2: BMI 18.5 - 29.9kg/m2 Aged 19 - 64 White-Caucasian Exclusion Criteria cohort 2: Smoker Vegetarian or vegan Suffering from food allergies or intolerances Drinking alcohol above recommended UK government guidelines Previous diagnosis of CM disease Taking lipid-lowering medication Taking blood pressure-lowering medication Taking blood glucose-lowering medication Taking dietary supplements Suffering from an eating disorder Current or previous renal impairment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ian G Davies, PhD
Organizational Affiliation
Liverpool John Moores University
Official's Role
Study Chair
Facility Information:
Facility Name
Liverpool John Moores University
City
Liverpool
State/Province
Merseyside
ZIP/Postal Code
L17 6BD
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed/12679447
Description
Brehm, B. et al. (2003) A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women J Clin Endocrinol Metab 88(4), 1617
URL
http://www.ncbi.nlm.nih.gov/pubmed/24552752
Description
Buyken, A., Goletzke, J., Joslowski, G., Felbick, A., Cheng, G., Herder, C. and Brand-Miller, J. (2014) Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies Am J Clin Nutr 99(4),
URL
http://www.ncbi.nlm.nih.gov/pubmed/24589564
Description
De Larochellière, E. et al. (2014) Visceral/epicardial adiposity in nonobese and apparently healthy young adults: association with the cardiometabolic profile Ath
URL
http://www.ncbi.nlm.nih.gov/pubmed/26024544
Description
Fischer, K., Pick, J., Moewes, D. and Nöthlings, U. (2015) Qualitative aspects of diet affecting visceral and subcutaneous abdominal adipose tissue: a systematic review of observational and controlled intervention studies Nutr Rev 73(4), 191-215
URL
http://www.ncbi.nlm.nih.gov/pubmed/23223345
Description
Gadgil, M., Appel, L., Yeung, E., Anderson, C., Sacks, F. and Miller, E. (2013) The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial Diabetes Care 36 (5), 1132-1137
URL
http://www.ncbi.nlm.nih.gov/pubmed/25089189
Description
Gardner, C. (2012) Tailoring dietary approaches for weight loss Int J Obes Suppl 2(Suppl 1), S11-S15
URL
http://www.ncbi.nlm.nih.gov/pubmed/26393645
Description
Hu, T. and Bazzano, L. (2014) The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies Nutr Metab Cardiovasc Dis 24(4), 337-343
URL
http://www.ncbi.nlm.nih.gov/pubmed/27114827
Description
Hu, T., Yao, L., Reynolds, K., Niu, T., Li, S., Whelton, P., He, J., Steffen, L. and Bazzano, L. (2016) Adherence to low-carbohydrate and low-fat diets in relation to weight loss and cardiovascular risk factors Obes Sci Pract, 2(1), 24-3
URL
http://www.ncbi.nlm.nih.gov/pubmed/25912185
Description
Ko, B., Park, K., Shin, S., Zaichenko, L., Davis, C., Crowell, J., Joung, H. and Mantzoros, C (2016) Diet quality and diet patterns in relation to circulating cardiometabolic biomarkers Clin Nutr. 35(2), 484-90
URL
http://www.ncbi.nlm.nih.gov/pubmed/23068073
Description
Lee, M., Wu, Y. and Fried, S. (2013) Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications Mol Aspects Med 34 (1), 1-11
URL
http://www.ncbi.nlm.nih.gov/pubmed/23803881
Description
Lennerz, B., Alsop, D., Holsen, L., Stern, E., Rojas, R., Ebbeling, C., Goldstein, J.and Ludwig, D. (2013) Effects of dietary glycemic index on brain regions related to reward and craving in men Am J Clin Nutr 98(3), 641-647
URL
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924165/
Description
Allam-Ndoul, B., Guénard, F., Garneau, V., Cormier, H., Barbier, O., Pérusse, L., et al. (2016) Association between Metabolite Profiles, Metabolic Syndrome and Obesity Status. Nutrients 8(6)
URL
http://www.ncbi.nlm.nih.gov/pubmed/22539584
Description
Lin, Z., Gong, Q., Wu, C., Yu, J., Lu, T., Pan, X., Lin, S. and Li, X. (2012) 'Dynamic change of serum FGF21 levels in response to glucose challenge in human J Clin Endocrinol Metab, 97(7), E1224-1228.

Learn more about this trial

CALIBER Phase 1: A Pilot Study in Normal-weight and Overweight Adults.

We'll reach out to this number within 24 hrs